As of Friday close, agilon health inc.’s (NYSE:AGL) stock was up $0.62, moving up 2.38 percent to $26.70. The average number of shares traded per day over the past five days has been 2,445,240 shares. 5 times new highs have been achieved over the past 5 days, with a $3.86 gain in that time frame. In the last twenty days, the average volume was 2,656,385, while in the previous 50 days, it was 2,255,052.
Since last month, AGL stock rose 13.14%. Shares of the company fell to $20.59 on 02/24/23, the lowest level in the past month. A 52-week high of $28.36 was reached on 03/17/23 after having rallying from a 52-week low of $14.82. Since the beginning of this year, AGL’s stock price has risen by 65.43% or $10.56, and marked a new high 19 times. However, the stock has declined by -5.85% since its 52-week high.
From Robots to Self-Driving Cars: 5 AI Stocks to Consider for Your Portfolio
The artificial intelligence (AI) revolution is already here and it's about to change everything we know about everything. With the global market for AI projected to grow from $137 billion in 2022 to over $1.81 trillion by 2030, there's never been a better time to invest in this burgeoning industry. That's why we've compiled a list of the Top 5 AI Stocks to Buy for 2023. These companies are at the forefront of the AI revolution, and have the potential to deliver huge returns to investors like you.
Get our free report, "Top 5 AI Stocks to Buy for 2023".
AGL stock investors should be aware that agilon health inc. (AGL) stock had its last reported insider trading activity 2 days ago on Mar 16. Desai Veeral, the Chief Strategy & Dev. Officer of the company, disposed of 60,000 shares for $26.09 on Mar 16. It resulted in a $1,565,196 divestment by the insider. Shaker Benjamin sold 25,000 shares at an average price of $25.60 on Mar 16. The insider now owns 60,625 shares following the transaction. On Mar 15, Director Wulf John William sold 80,000 shares at $23.82 apiece. The transaction was valued at $1,905,224.
In the three months ended December 30, agilon health inc.’s quick ratio stood at 2.70, while its current ratio was 2.70, showing that the company is able to pay off its debt. According to company report, the long-term debt-to-equity ratio for the quarter ending December 30 was 0.04, and the total debt-to-equity ratio was 0.04. On the profitability front, the trailing twelve-month gross margin is 11.40% percent. In the year ended December 30, operating margins totaled -4.60%. Based on annual data, AGL earned $112.29 million in gross profit and brought in $2.71 billion in revenue.
A company’s management is another factor that investors consider when determining the profitability of an investment. In the past year, return on investment (ROI) was -11.80%. Return on equity (ROE) for the past 12 months was -9.80%.
In agilon health inc.’s quarter-end financial report for December 30, it reported total debt of $38.48 million against cash and short-term investments of $411.9 million. According to the earnings report, the company had a lower net income in the recent quarter than it did in the previous quarter. AGL’s revenue rose 32.89% to $694.86 million during the quarter, while net income inched up to $689.77 million. While analysts expected agilon health inc. to report -$0.09 quarterly earnings, the actual figure was -$0.14 per share, beating the consensus estimate by -55.60%. During the quarter, the company generated -$65.21 million in EBITDA. The liabilities of agilon health inc. were 656.86 million at the end of its most recent quarter ended December 30, and its total debt was $57.07 million. The value of shareholders’ equity is $413.12 million.
This quick technical analysis looks at agilon health inc.’s (AGL) price momentum. With a historical volatility rate of 54.63%, the RSI 9-day stood at 73.80% on 17 March.
With respect to its five-day moving average, the current agilon health inc. price is up by +16.90% percent or $3.86. At present, AGL shares trade +13.23% above its 20-day simple moving average and +32.51% percent above its 100-day simple moving average. However, the stock is currently trading approximately +65.63% above its SMA50 and +39.79% above its SMA200.
Stochastic coefficient K was 85.18% and Stochastic coefficient D was 71.70%, while ATR was 1.21. Given the Stochastic reading of 95.09% for the 14-day period, the RSI (14) reading has been calculated as 69.87%. As of today, the MACD Oscillator reading stands at 1.21, while the 14-day reading stands at 1.60.